Oscar Health Announces Results for Fourth Quarter and Full Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Oscar Health Inc (OSCR) PT Lowered to $8 at Cowen
February 11, 2022 7:10 AM ESTCowen analyst Gary Taylor lowered the price target on Oscar Health Inc (NYSE: OSCR) to $8.00 (from $15.00) while maintaining a Market Perform rating.
The analyst commented, "On 1/27/22 OSCR previewed 4Q21 results and initiated 2022 guidance. Full results tonight reveal a $40m PDR benefit in 4Q21;... More
Oscar Health Inc. (OSCR) Tops Q4 EPS by 12c
February 10, 2022 4:28 PM ESTOscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.95), $0.12 better than the analyst estimate of ($1.07). Revenue for the quarter came in at $496.07 million, versus $157.67 million reported last year.
Direct and assumed premiums of $3,437 million, a 50% increase YoYPremiums earned of $1,831 million, a 302%... More